Matador Resources is nursing its worst two-week stretch in months, down 13% to $53.78 while the analyst consensus points to a $73 mean target — a gap that tells you where the debate now sits.
The selloff is broad but steeper for MTDR than most of its neighbours. Close peer CHRD fell 7.8% on the week and APA dropped 6.6%. Even the larger names — OXY and FANG — gave up only 3.8% and 5.1% respectively. Matador's 12.9% weekly decline is the worst performer in the group by a clear margin, amplifying an oil-price selloff that has hit the whole E&P sector.
The lending market is not telling a crowded short story. Short interest is broadly flat on the week, edging up just 0.65% to 7.4% of the free float — modest movement for a stock that just lost an eighth of its value. Borrow remains almost free at 0.44%, barely changed over the month. Availability has actually loosened sharply: at 542%, roughly five shares are available for every one currently borrowed, up from 357% at the early-May peak and well above the 52-week low of 336%. The ORTEX short score of 52.6 confirms the same read — positioned in the middle of the range, not at an extreme. If conviction bears were piling in, availability would be tightening and borrow costs rising. Neither is happening.
Options are pointing the same direction as the bulls. The put/call ratio has dropped to 0.34, near its 52-week low of 0.32 and well below its 20-day average of 0.36. That's 1.4 standard deviations light on put demand — options traders are not reaching for downside protection despite the drop. The contrast with the price action is the interesting tension this week: the stock is bleeding, but neither the derivatives market nor the borrow market shows the defensive setup you'd expect if institutions were repositioning for more pain.
Analyst activity has been unusually busy and largely constructive. Mizuho raised its target to $77 this morning, maintaining Outperform — the second Mizuho action in three weeks after cutting to $74 post-earnings in early May. Morgan Stanley nudged its target to $75, also keeping Equal-Weight. Citigroup trimmed its target slightly to $72 but held Buy. The net message: even after the Q1 earnings drop of 4.3% on the day and the subsequent slide, most of the Street has not abandoned conviction on the name. Mean target of $73 against a $53.78 close implies 36% implied upside — the widest that gap has been in some time. Valuation reinforces the picture: the P/E has compressed to 6.8x and the EV/EBITDA to 3.9x, both down meaningfully over the past 30 days as the stock has de-rated faster than earnings estimates. The bull case rests on the Delaware Basin franchise, San Mateo midstream optionality, and one of the lower base-decline rates in the peer group. The bear case is simpler: oil price direction, Waha basis exposure, and the question of whether the midstream JV process resolves cleanly.
One factor worth tracking is the earnings calendar. The Q1 print on May 7 produced an 11.7% one-day drop and a further 8.9% over five days — a notably weak reaction. The next report is pencilled for August 4. Between now and then, the stock's trajectory will be tightly tethered to crude prices and any update on the San Mateo process. The disconnect between a widening analyst upside estimate and a borrow market that sees no urgency to press shorts is the key dynamic to watch into summer.
See the live data behind this article on ORTEX.
Open MTDR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
